Results 181 to 190 of about 9,912 (208)

Vildagliptin

Reactions Weekly, 2016
openaire   +1 more source

[Vildagliptin].

Nihon rinsho. Japanese journal of clinical medicine, 2011
openaire   +3 more sources

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study

Lancet, The, 2013
W David Strain, Päivi Maria Paldánius DMed   +1 more
exaly  

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

Lancet, The, 2019
Michael Stumvoll, Stefano Del Prato
exaly  

Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin

Clinical Pharmacokinetics, 2012
Yan-Ling He
exaly  

Vildagliptin

Drugs of the Future, 2004
null McIntyre, J.A., null Castaner, J.
openaire   +1 more source

Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice

Metabolism: Clinical and Experimental, 2015
Chun-jun Li, Dai-Qing Li, Hang Guo
exaly  

Vildagliptin Improves Endothelium-Dependent Vasodilatation in Type 2 Diabetes

Diabetes Care, 2011
Pleun C M Van Poppel, Cornelis J Tack
exaly  

The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice

Diabetologia, 2018
Marta Olivares, Audrey M Neyrinck, Nathalie M. Delzenne   +2 more
exaly  

Fifty‐two‐week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Diabetes, Obesity and Metabolism, 2009
exaly